GSK-Vir COVID-19 Therapy Effective Against All Mutations Of Omicron Coronavirus Variant, Data Suggest
December 08, 2021
Reuters (12/7, Aripaka) reports GlaxoSmithKline “said on Tuesday its antibody-based COVID-19 therapy with U.S. partner Vir Biotechnology...is effective against all mutations of the new Omicron coronavirus variant, citing new data from early-stage studies....